JVL Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Sell
692
-122
-15% -$49.1K 0.07% 69
2026
Q2
$338K Buy
+814
New +$302K 0.1% 56
2025
Q2
– Sell
-483
Closed -$253K – 66
2025
Q1
$253K Sell
483
-13
-3% -$6.65K 0.1% 51
2024
Q4
$251K Buy
496
+4
+0.8% +$2.27K 0.1% 49
2024
Q3
$288K Buy
492
+24
+5% +$13.6K 0.11% 45
2024
Q2
$238K Buy
468
+16
+4% +$7.84K 0.1% 48
2024
Q1
$224K Buy
452
+17
+4% +$8.64K 0.09% 50
2023
Q4
$229K Buy
+435
New +$232K 0.1% 41

Other funds holding UNH

JVL Associates's UNH Position: Q3 2026 in Review

JVL Associates reduced its UnitedHealth (UNH) stake by 15% in Q3 2026, selling an estimated $49.1K and leaving 692 shares worth $254K. The position accounts for 0.07% of the portfolio, ranked #69.

JVL Associates first reported a position in UNH in Q4 2023 and has held it in 8 quarters since. The position peaked at $338K in Q2 2026. 2,421 funds tracked by Wall St. Rank hold UNH as of Q3 2026.

  • JVL Associates held 692 shares of UnitedHealth worth $254K as of Q3 2026.
  • JVL Associates sold 122 UnitedHealth shares in Q3 2026, an estimated $49.1K.
  • UnitedHealth made up 0.07% of JVL Associates's portfolio in Q3 2026, its #69 holding.
  • JVL Associates first reported a position in UnitedHealth in Q4 2023 and has held it in 8 quarters since.
  • JVL Associates's UnitedHealth position peaked at $338K in Q2 2026.
  • 2,421 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2026.

Based on JVL Associates's 13F filing for Q3 2026, filed 9 Oct 2026.